New cancer vaccine seeks to train immune system to fight advanced tumors
Disease control
Ongoing
This study is testing a new genetic vaccine, called Nous-209, given alongside the immunotherapy drug pembrolizumab (Keytruda®). The goal is to see if this combination is safe and can help control advanced cancers that have a specific genetic feature (MSI-H or dMMR), including col…
Phase: PHASE1, PHASE2 • Sponsor: Nouscom SRL • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC